Artikel ; Online: Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms.
Expert review of gastroenterology & hepatology
2024 Band 18, Heft 4-5, Seite(n) 155–169
Abstract: Introduction: Pancreatic Neuroendocrine Neoplasms (PanNENs) are characterized by a highly heterogeneous clinical and biological behavior, making their diagnosis challenging. PanNENs diagnostic work-up mainly relies on biochemical markers, pathological ... ...
Abstract | Introduction: Pancreatic Neuroendocrine Neoplasms (PanNENs) are characterized by a highly heterogeneous clinical and biological behavior, making their diagnosis challenging. PanNENs diagnostic work-up mainly relies on biochemical markers, pathological examination, and imaging evaluation. The latter includes radiological imaging (i.e. computed tomography [CT] and magnetic resonance imaging [MRI]), functional imaging (i.e. 68Gallium [68 Ga]Ga-DOTA-peptide PET/CT and Fluorine-18 fluorodeoxyglucose [18F]FDG PET/CT), and endoscopic ultrasound (EUS) with its associated procedures. Areas covered: This review provides a comprehensive assessment of the recent advancements in the PanNENs diagnostic field. PubMed and Embase databases were used for the research, performed from inception to October 2023. Expert opinion: A deeper understanding of PanNENs biology, recent technological improvements in imaging modalities, as well as progresses achieved in molecular and cytological assays, are fundamental players for the achievement of early diagnosis and enhanced preoperative characterization of PanNENs. A multimodal diagnostic approach is required for a thorough disease assessment. |
---|---|
Mesh-Begriff(e) | Humans ; Pancreatic Neoplasms/diagnostic imaging ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/pathology ; Neuroendocrine Tumors/diagnostic imaging ; Neuroendocrine Tumors/diagnosis ; Endosonography ; Biomarkers, Tumor/analysis ; Magnetic Resonance Imaging ; Positron Emission Tomography Computed Tomography ; Radiopharmaceuticals |
Chemische Substanzen | Biomarkers, Tumor ; Radiopharmaceuticals |
Sprache | Englisch |
Erscheinungsdatum | 2024-05-02 |
Erscheinungsland | England |
Dokumenttyp | Journal Article ; Review |
ZDB-ID | 2481021-6 |
ISSN | 1747-4132 ; 1747-4124 |
ISSN (online) | 1747-4132 |
ISSN | 1747-4124 |
DOI | 10.1080/17474124.2024.2342837 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 6978: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.